¾àÇ°¸í |
Lyrica¨Þ Capsule
C |
Neurontin¨Þ Capsule
C |
¼ººÐ¸í |
Pregabalin 75mg |
Gabapentin 300mg |
¾à¸®
ÀÛ¿ë |
a. Voltage-gated Ca2+channelsÀÇ
º¸Á¶Àû ¾Æ´ÜÀ§(¥á2/¥ä protein)¿¡ °áÇÕ
¢¡[3H]-gabapentinÀ» °ÇÏ°Ô Ä¡È¯
b. ¥á2/¥ä subunit¿¡¼ÀÇ ´Ü¹é°áÇÕ ¢¡
¨ç ½Å°æ¸»´Ü¿¡¼ÀÇ Ca2+
À¯ÀÔ°¨¼Ò ¨è neuro-transmitterºÐºñ
°¨¼Ò (ex.
glutamate, NE, substance P) ¡Å
ÁøÅë, Ç×ºÒ¾È ¹× Ç×Àü°£È¿°ú³ªÅ¸³¿
c. GABAA ¿Í GABAB receptor¿¡
ºÒÈ°¼º |
a. Interference with direct potentiation
of GABAergic neurotransmission
via interaction with a facilitatory presynaptic
GABAA receptor
b. GABA¿Í ´Þ¸® BBB¸¦ Åë°úÇϸç GABAB (baclofen)
or GABAc siteÀÇ ligand´Â ¾Æ´Ô.
c. GABAº¸´Ù MWÀÌ ´õ Å©°í ´õ Áö¿ë¼ºÀÌ´Ù. |
¾à
¹°
µ¿
·Â
ÇÐ |
Tmax |
¡´1hr |
1~3hr |
PB |
´Ü¹é°áÇÕÇÏÁö
¾ÊÀ½ |
¡´ 3% |
T1/2 |
6.3hr |
5~6hr |
°£´ë»ç |
No |
No (°ÅÀÇ
´ë»ç ¾È µÊ) |
¹è¼³ |
´¢:
98%(¹Ìº¯Èü) |
´¢:
80%(¹Ìº¯Èü), º¯:10~23% |
BA |
¡µ90% |
80% |
Vd |
0.56L/kg |
0.8L/kg |
ÀûÀÀÁõ |
- |
¨çôÃß¼Õ»ó ¹× Àý´Ü¿¡ ÀÇÇÑ ½Å°æº´Áõ¼º ÅëÁõ
¨èº¹ÇÕºÎÀ§ ÅëÁõ ÁõÈıº
¨é»ïÂ÷½Å°æÅë, ¾Ï¼º ½Å°æº´Áõ¼º ÅëÁõ
¨ê´Ù¹ß¼º °æÈÁõ
¨ëÇǺ긮º´ |
a. Neuropathic
pain (´ç´¢º´¼º, ´ë»óÆ÷Áø ÈÄ )
b. Partial seizure º¸Á¶¿ä¹ý (2Â÷ÀûÀÎ Àü½ÅÁõ»óÀÌ ¼ö¹ÝµÇ°Å³ª
¼ö¹ÝµÇÁö ¾ÊÀº °æ¿ì Æ÷ÇÔ)
GABA receptor |
Transduction |
Effect |
A |
linked to chloride channels¡æ hyperpolarisation |
inhibition of transmission |
B |
ProteinGout
:¡éCa++ or K+
ProteinGin
: ¡é AMPc |
C |
linked to chloride channels |
|
FDA
ÀûÀÀÁõ |
-¼ºÀÎÀÇ Partial-onset seizureÀÇ
º¸Á¶¿ä¹ý |
(Lyrica
18¼¼ ÀÌ»ó) |
(Neurontin
3¼¼ ÀÌ»ó) |
-Neuropathic pain
(´ç´¢º´¼º, ´ë»óÆ÷Áø ÈÄ µî) |
(non FDA) Diabetic peripheral
neuropathy Miagraine,
Prophylaxis, social phobia |
¿ë¹ý |
150~600mg #1~2 (max: 600mg/d) À½½Ä¹°°ú
»ó°ü¾øÀÌ Åõ¿©
a. Neuropathic pain : 150mg/d¡¿3~7d ¢¡ 300mg/d¡¿7d
b. Partial seizure º¸Á¶¿ä¹ý : 150mg/d¡¿1wk
¢¡ 300mg/d¡¿1wk |
300mg qd¡¿1d¡æbid¡¿1d¡ætid¡¿1d·Î Åõ¿©ÇÏ¿©
a. Neuropathic pain : max 1,800mg/d
b. Partial seizure º¸Á¶¿ä¹ý: 900~1800mg/d
# 3 (max 2,400mg/d) [3~12y]
10~15mg/kg/d # 3 |
c. ½ÅºÎÀü ¹×
Ç÷¾×Åõ¼®È¯ÀÚ´Â ¿ë·® °¨¼Ò Á¶Àý |
ºÎÀÛ¿ë |
½Ä¿åÁõ°¡, ´ÙÇà°¨, Çö±âÁõ, Á¹À½, ³½Ã, º¹½Ã, Çö±âÁõ, ±¸°¥, ¿À½É,
º¯ºñ, ¹è´¢°ï¶õ, ´¢½Ç±Ý, ÇÇ·Î, ºÎÁ¾, º¸ÇàÀÌ»ó |
Á¹À½, Çö±âÁõ, ¿îµ¿½ÇÁ¶, ÇÇ·Î, µÎÅë, ±ÙÀ°Åë, ¾È±¸ÁøÅÁÁõ, ³½Ã,
º¹½Ã. ¿À½É, ÇǺιßÁø. |
¾à¹°
»óÈ£
ÀÛ¿ë |
- |
a. Á¦»êÁ¦ º´¿ë½Ã gabapentinÀÇ BAÀ» 20% °¨¼Ò
¢¡ Á¦»êÁ¦ »ç¿ë 2½Ã°£
ÈÄ gabapentinÀÇ »ç¿ëÀ¸·Î »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈ
b. gabapentin enzyme inducing Ç×Àü°£Á¦°¡ ¾Æ´Ô |
±Ý±â |
- º»Á¦¿¡ °ú¹ÎÀÚ
- galactose intolerance, Lapp lactose deficiency
¶Ç´Â glucose-galactose malabsorptionÀÇ À¯ÀüÀûÀÎ ¹®Á¦°¡
ÀÖ´Â ÀÚ |
º¸Çè¾à°¡ |
1,085¿ø/75mg (Çѱ¹ÈÀÌÀÚ) |
760¿ø/300mg (Çѱ¹ÈÀÌÀÚ) |
1ÀϾడ |
1,085~4,340¿ø (75~600mg) |
760~6,080¿ø (300~2,400mg) |